(ESE) ESCO Technologies - Ratings and Ratios
Filtration, Fluid-Control, RF-Test, Aerospace, Defense
Dividends
| Dividend Yield | 0.20% |
| Yield on Cost 5y | 0.40% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 53.0% |
| Payout Ratio | 5.1% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 29.1% |
| Value at Risk 5%th | 47.2% |
| Relative Tail Risk | -1.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.04 |
| Alpha | 28.95 |
| CAGR/Max DD | 1.93 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.447 |
| Beta | 0.951 |
| Beta Downside | 1.009 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.52% |
| Mean DD | 5.56% |
| Median DD | 4.38% |
Description: ESE ESCO Technologies November 05, 2025
ESCO Technologies Inc. (NYSE:ESE) designs and manufactures engineered filtration and fluid-control products, as well as integrated propulsion systems for aerospace and defense, while also delivering diagnostic testing tools for electric-grid operators and RF-test & measurement solutions for R&D, regulatory, medical, and security applications.
In FY 2023 the company reported roughly $210 million in revenue, with a 12% year-over-year increase driven largely by higher demand for aerospace aftermarket filters and a modest uptick in defense contracts; however, the growth rate is sensitive to cyclical airline traffic recovery and federal defense budget allocations, which analysts estimate will rise about 6% in FY 2024.
The Utility Solutions Group benefits from the accelerating grid-modernization agenda in the United States, where capital spending on high-voltage equipment diagnostics is projected to exceed $5 billion over the next three years, while the RF Test & Measurement segment is positioned in a market expected to expand at a 5% CAGR, bolstered by expanding 5G infrastructure and increasing regulatory scrutiny of electromagnetic emissions.
ESCO distributes its diversified product portfolio through a mix of independent distributors, direct sales teams, and in-house representatives, and has operated out of its Saint Louis headquarters since its 1990 incorporation.
Consider exploring ValueRay for deeper analytics on ESE’s valuation metrics and comparative industry benchmarks.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (299.2m TTM) > 0 and > 6% of Revenue (6% = 69.7m TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA 4.27pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 15.53% (prev 31.05%; Δ -15.52pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 241.9m <= Net Income 299.2m (YES >=105%, WARN >=100%) |
| Net Debt (109.1m) to EBITDA (245.4m) ratio: 0.44 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.35 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (25.9m) change vs 12m ago 0.22% (target <= -2.0% for YES) |
| Gross Margin 45.39% (prev 38.51%; Δ 6.88pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 54.88% (prev 55.84%; Δ -0.97pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.73 (EBITDA TTM 245.4m / Interest Expense TTM 17.5m) >= 6 (WARN >= 3) |
Altman Z'' 4.64
| (A) 0.08 = (Total Current Assets 688.5m - Total Current Liabilities 508.1m) / Total Assets 2.39b |
| (B) 0.57 = Retained Earnings (Balance) 1.37b / Total Assets 2.39b |
| (C) 0.08 = EBIT TTM 170.4m / Avg Total Assets 2.12b |
| (D) 1.65 = Book Value of Equity 1.37b / Total Liabilities 830.9m |
| Total Rating: 4.64 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 73.24
| 1. Piotroski 6.50pt |
| 2. FCF Yield 3.85% |
| 3. FCF Margin 17.70% |
| 4. Debt/Equity 0.13 |
| 5. Debt/Ebitda 0.44 |
| 6. ROIC - WACC (= -1.09)% |
| 7. RoE 22.15% |
| 8. Rev. Trend 82.53% |
| 9. EPS Trend 77.66% |
What is the price of ESE shares?
Over the past week, the price has changed by +4.39%, over one month by -7.24%, over three months by -1.94% and over the past year by +43.66%.
Is ESE a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ESE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 255 | 24.9% |
| Analysts Target Price | 255 | 24.9% |
| ValueRay Target Price | 263.2 | 28.9% |
ESE Fundamental Data Overview December 06, 2025
P/E Trailing = 45.0535
P/S = 4.7731
P/B = 3.3712
P/EG = 1.96
Beta = 1.215
Revenue TTM = 1.16b USD
EBIT TTM = 170.4m USD
EBITDA TTM = 245.4m USD
Long Term Debt = 166.0m USD (from longTermDebt, last quarter)
Short Term Debt = 20.0m USD (from shortTermDebt, last quarter)
Debt = 210.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 109.1m USD (from netDebt column, last quarter)
Enterprise Value = 5.34b USD (5.23b + Debt 210.4m - CCE 101.3m)
Interest Coverage Ratio = 9.73 (Ebit TTM 170.4m / Interest Expense TTM 17.5m)
FCF Yield = 3.85% (FCF TTM 205.6m / Enterprise Value 5.34b)
FCF Margin = 17.70% (FCF TTM 205.6m / Revenue TTM 1.16b)
Net Margin = 25.76% (Net Income TTM 299.2m / Revenue TTM 1.16b)
Gross Margin = 45.39% ((Revenue TTM 1.16b - Cost of Revenue TTM 634.3m) / Revenue TTM)
Gross Margin QoQ = 56.05% (prev 41.17%)
Tobins Q-Ratio = 2.23 (Enterprise Value 5.34b / Total Assets 2.39b)
Interest Expense / Debt = 2.44% (Interest Expense 5.13m / Debt 210.4m)
Taxrate = 24.94% (12.3m / 49.3m)
NOPAT = 127.9m (EBIT 170.4m * (1 - 24.94%))
Current Ratio = 1.35 (Total Current Assets 688.5m / Total Current Liabilities 508.1m)
Debt / Equity = 0.13 (Debt 210.4m / totalStockholderEquity, last quarter 1.56b)
Debt / EBITDA = 0.44 (Net Debt 109.1m / EBITDA 245.4m)
Debt / FCF = 0.53 (Net Debt 109.1m / FCF TTM 205.6m)
Total Stockholder Equity = 1.35b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.50% (Net Income 299.2m / Total Assets 2.39b)
RoE = 22.15% (Net Income TTM 299.2m / Total Stockholder Equity 1.35b)
RoCE = 11.23% (EBIT 170.4m / Capital Employed (Equity 1.35b + L.T.Debt 166.0m))
RoIC = 8.13% (NOPAT 127.9m / Invested Capital 1.57b)
WACC = 9.22% (E(5.23b)/V(5.44b) * Re(9.52%) + D(210.4m)/V(5.44b) * Rd(2.44%) * (1-Tc(0.25)))
Discount Rate = 9.52% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.16%
[DCF Debug] Terminal Value 76.79% ; FCFE base≈155.1m ; Y1≈191.3m ; Y5≈326.4m
Fair Price DCF = 164.9 (DCF Value 4.26b / Shares Outstanding 25.8m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 77.66 | EPS CAGR: 53.96% | SUE: 1.50 | # QB: 1
Revenue Correlation: 82.53 | Revenue CAGR: 20.18% | SUE: -1.13 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.69 | Chg30d=+0.060 | Revisions Net=+0 | Analysts=2
EPS current Year (2026-09-30): EPS=7.71 | Chg30d=+0.450 | Revisions Net=+1 | Growth EPS=+27.9% | Growth Revenue=+17.8%
EPS next Year (2027-09-30): EPS=8.79 | Chg30d=+0.660 | Revisions Net=+1 | Growth EPS=+14.0% | Growth Revenue=+6.9%
Additional Sources for ESE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle